MedPath

University of Oxford

University of Oxford logo
🇬🇧United Kingdom
Ownership
Private
Established
1096-01-01
Employees
10K
Market Cap
-
Website
http://www.ox.ac.uk

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG

Phase 1
Completed
Conditions
Tuberculosis
First Posted Date
2007-01-29
Last Posted Date
2007-01-29
Lead Sponsor
University of Oxford
Target Recruit Count
16
Registration Number
NCT00427830
Locations
🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, Oxfordshire, United Kingdom

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Phase 1
Completed
Conditions
Tuberculosis
First Posted Date
2007-01-29
Last Posted Date
2007-01-29
Lead Sponsor
University of Oxford
Target Recruit Count
12
Registration Number
NCT00427453
Locations
🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, Oxfordshire, United Kingdom

Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

Phase 2
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2007-01-18
Last Posted Date
2008-08-07
Lead Sponsor
University of Oxford
Target Recruit Count
66
Registration Number
NCT00423280
Locations
🇬🇧

Department of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom

A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers

Phase 1
Completed
Conditions
Tuberculosis
First Posted Date
2007-01-18
Last Posted Date
2007-01-18
Lead Sponsor
University of Oxford
Target Recruit Count
12
Registration Number
NCT00423839
Locations
🇬🇲

MRC Labs, Fajara, Gambia

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Phase 1
Completed
Conditions
Tuberculosis
First Posted Date
2007-01-18
Last Posted Date
2007-01-18
Lead Sponsor
University of Oxford
Target Recruit Count
14
Registration Number
NCT00423566
Locations
🇬🇧

University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen

Phase 1
Completed
Conditions
Malaria
Malaria, Falciparum
First Posted Date
2006-12-07
Last Posted Date
2006-12-07
Lead Sponsor
University of Oxford
Target Recruit Count
30
Registration Number
NCT00408668
Locations
🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV

Phase 1
Completed
Conditions
Tuberculosis
HIV Infections
Interventions
Biological: MVA85A (TB vaccine)
Biological: MVA 85A
First Posted Date
2006-11-03
Last Posted Date
2011-03-28
Lead Sponsor
University of Oxford
Target Recruit Count
20
Registration Number
NCT00395720
Locations
🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia

Phase 3
Completed
Conditions
Esophageal Cancer
Precancerous Condition
Interventions
First Posted Date
2006-07-27
Last Posted Date
2025-05-01
Lead Sponsor
University of Oxford
Target Recruit Count
2557
Registration Number
NCT00357682

Effect of Folic Acid Treatment in Coronary Artery Disease

Phase 2
Conditions
Coronary Artery Disease
First Posted Date
2006-03-08
Last Posted Date
2008-08-07
Lead Sponsor
University of Oxford
Target Recruit Count
60
Registration Number
NCT00300352
Locations
🇬🇧

University of Oxford, Oxford, United Kingdom

Self-Help Parent Training for Conduct Problems in Children

Phase 3
Conditions
Behavioral Symptoms
Interventions
Behavioral: Self-help Triple P Behavioural Family Intervention
First Posted Date
2006-03-06
Last Posted Date
2009-03-12
Lead Sponsor
University of Oxford
Target Recruit Count
70
Registration Number
NCT00299442
Locations
🇬🇧

Sue Nicholls Centre, Aylesbury, Bucks, United Kingdom

🇬🇧

Wycombe CAMHS, High Wycombe, Buckinghamshire, United Kingdom

🇬🇧

West Berkshire PCT, Reading, Berkshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath